| 000 | 05309nam a2201249Ia 4500 | ||
|---|---|---|---|
| 000 | 03719cam a2200505Ii 4500 | ||
| 001 | 43393 | ||
| 003 | 0 | ||
| 005 | 20250920160759.0 | ||
| 008 | 081206s2008 sz b 001 0 eng d | ||
| 010 |
_z _z _o _a _b |
||
| 015 |
_22 _a |
||
| 016 |
_2 _2 _a _z |
||
| 020 |
_e _e _a9789241547581;9241547588 _b _z _c _q _x |
||
| 022 |
_y _y _l _a2 |
||
| 024 |
_2 _2 _d _c _a _q |
||
| 028 |
_a _a _b |
||
| 029 |
_a _a _b |
||
| 032 |
_a _a _b |
||
| 035 |
_a _a(OCoLC)277203775 _b _z _c _q |
||
| 037 |
_n _n _c _a _b |
||
| 040 |
_e _erda _aBTCTA _dSDB;YDXCP;OKH;IXA;PUL;BWX;COD;UtOrBLW _b _cBTCTA |
||
| 041 |
_e _e _a _b _g _h _r |
||
| 043 |
_a _a _b |
||
| 045 |
_b _b _a |
||
| 050 |
_a _aRA644.T7 _d _bG85 20082 _c0 |
||
| 051 |
_c _c _a _b |
||
| 055 |
_a _a _b |
||
| 060 |
_a _a _b |
||
| 070 |
_a _a _b |
||
| 072 |
_2 _2 _d _a _x |
||
| 082 |
_a _a _d _b2 _c |
||
| 084 |
_2 _2 _a |
||
| 086 |
_2 _2 _a |
||
| 090 |
_a _a _m _b _q |
||
| 092 |
_f _f _a _b |
||
| 096 |
_a _aWF 310 _bG3468 2208 |
||
| 097 |
_a _a _b |
||
| 100 |
_e _e _a _d _b4 _u _c0 _q16 |
||
| 110 |
_e _e _a _d _b _n _c _k |
||
| 111 |
_a _a _d _b _n _c |
||
| 130 |
_s _s _a _p _f _l _k |
||
| 210 |
_a _a _b |
||
| 222 |
_a _a _b |
||
| 240 |
_s _s _a _m _g _n _f _l _o _p _k |
||
| 245 | 0 |
_a _aGuidelines for the programmatic management of drug-resistant tuberculosis : _d _b[emergency update 2008] / _n _c[Steering Group, Ernesto Jaramillo ... et al.] _h6 _p |
|
| 246 |
_a _a _b _n _i _f6 _p |
||
| 249 |
_i _i _a |
||
| 250 |
_6 _6 _aEmergency update. _b |
||
| 260 |
_e _e _a _b _f _c _g |
||
| 264 |
_3 _3 _aGeneva : _d _bWorld Health Organization, Stop TB Department, _c[2008];copyright 2008.46 |
||
| 300 |
_e _e _c24 cm. _axxi, 247 p. _b |
||
| 310 |
_a _a _b |
||
| 321 |
_a _a _b |
||
| 336 |
_b _atext _2rdacontent |
||
| 337 |
_3 _30 _b _a2 |
||
| 338 |
_3 _30 _b _avolume _2rdacarrier |
||
| 340 |
_2 _20 _g _n |
||
| 344 |
_2 _2 _a0 _b |
||
| 347 |
_2 _2 _a0 |
||
| 362 |
_a _a _b |
||
| 385 |
_m _m _a2 |
||
| 410 |
_t _t _b _a _v |
||
| 440 |
_p _p _a _x _v |
||
| 490 |
_a _a _x _v |
||
| 500 |
_a _aWHO/HTM/TB/2008.402. _d _b _c56 |
||
| 504 |
_a _aIncludes bibliographical references and index. _x |
||
| 505 |
_a _aBackground information on DR-TB -- Framework for effective control of DR-TB -- Political commitment and coordination -- Definitions : case registration, bacteriology and treatment outcomes -- Case-finding strategies -- Laboratory aspects -- Treatment strategies for MDR-TB and XDR-TB -- Mono-resistant and poly-resistant strains -- Treatment of DR-TB in special conditions and situations -- DR-TB and HIV infection -- Initial evaluation, monitoring of treatment and management of adverse effects -- Treatment delivery and community-based DR-TB support -- Management of patients after MDR-TB treatment failure -- Management of contacts of MDR-TB patients -- Drug resistance and infection control -- Human resources : training and staffing -- Management of second-line antituberulosis drugs -- Category IV recording and reporting system -- Managing DR-TB through patient-centred care. _b _t _g _r |
||
| 506 |
_a _a5 |
||
| 510 |
_a _a _x |
||
| 520 |
_b _b _c _aThe emergence of extensively drug-resistant strains of tuberculosis, especially in countries with a high prevalence of human immunodeficiency virus, is a serious threat to global public health and jeopardizes efforts to effectively control the disease. This publication offers updated recommendations for the diagnosis and management of drug-resistant tuberculosis in a variety of geographical, economic and social settings, and the recording of data that enables the monitoring and evaluation of programs.--Publisher's description. _u |
||
| 521 |
_a _a _b |
||
| 530 | _aAlso available online. | ||
| 533 |
_e _e _a _d _b _n _c |
||
| 536 | _aFunded by the UK Department for International Development and the United States Agency for International Development. | ||
| 540 |
_c _c _a5 |
||
| 542 |
_g _g _f |
||
| 546 |
_a _a _b |
||
| 583 |
_5 _5 _k _c _a _b |
||
| 590 |
_a _a _b |
||
| 600 |
_b _b _v _t _c2 _q _a _x0 _z _d _y |
||
| 610 |
_b _b _v _t2 _x _a _k0 _p _z _d6 _y |
||
| 611 |
_a _a _d _n2 _c0 _v |
||
| 630 |
_x _x _a _d _p20 _v |
||
| 648 |
_2 _2 _a |
||
| 650 |
_x _xChemotherapy.;Prevention.;Chemotherapy.;Treatment.;drug therapy.;prevention & control.;administration & dosage.;drug therapy. _aMultidrug-resistant tuberculosis;Multidrug-resistant tuberculosis;Antitubercular agents.;HIV infections;Comorbidity;Highly active antiretroviral therapy.;Tuberculosis, Multidrug-Restant;Tuberculosis, Multidrug-Restant;Antitubercular Agents;HIV Infections;Antiretroviral Therapy, Highly Active. _d _b _z _y20 _v |
||
| 651 |
_x _x _a _y20 _v _z |
||
| 655 |
_0 _0 _a _y2 _z |
||
| 700 |
_i _i _t _c _b _s1 _q _f _k40 _p _d _e _aJaramillo, Ernesto. _l _n6 |
||
| 710 |
_b _bDepartment for International Development.;Agency for International Development. _t _c _e _f _k40 _p _d5 _l _n6 _aStop TB Initiative (World Health Organization);Great Britain.;United States. |
||
| 711 |
_a _a _d _b _n _t _c |
||
| 730 |
_s _s _a _d _n _p _f _l _k |
||
| 740 |
_e _e _a _d _b _n _c6 |
||
| 753 |
_c _c _a |
||
| 767 |
_t _t _w |
||
| 770 |
_t _t _w _x |
||
| 773 |
_a _a _d _g _m _t _b _v _i _p |
||
| 775 |
_t _t _w _x |
||
| 776 |
_s _s _a _d _b _z _i _t _x _h _c _w |
||
| 780 |
_x _x _a _g _t _w |
||
| 785 |
_t _t _w _a _x |
||
| 787 |
_x _x _d _g _i _t _w |
||
| 800 |
_a _a _d _l _f _t0 _q _v |
||
| 810 |
_a _a _b _f _t _q _v |
||
| 830 |
_x _x _a _p _n _l0 _v |
||
| 942 |
_a _alcc _cBK |
||
| 999 |
_c2163 _d2163 |
||